Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis

  • Yukari C. Manabe ,

    ymanabe@jhmi.edu

    Affiliations Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  • Sabine M. Hermans,

    Affiliations Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands

  • Mohammed Lamorde,

    Affiliations Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda, Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland

  • Barbara Castelnuovo,

    Affiliation Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda

  • C. Daniel Mullins,

    Affiliation University of Maryland, Baltimore, Maryland, United States of America

  • Andreas Kuznik

    Affiliation Pfizer Inc., New York, New York, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.